Why the Bod (ASX:BDA) share price is tracking 5% higher today

The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive trading update. Let's take a look.

| More on:
little green pharma share price represented by cannabis leaf character jumping cheerfully

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive trading update.

At the time of writing, shares in the cannabis healthcare company are trading 5.3% higher at 49.5 cents.

What's driving the Bod share price higher?

The company has delivered record sales for the second-quarter of the 2021 financial year.

For the period ending December 31, total attributable sales came in at $3.3 million. This represents a 52% lift on the previous quarter, and 144% increase over the same time last year.

The strong performance was underpinned by a number of purchase orders from Bod's exclusive global partner, Health & Happiness. The latter recently launched CBD and hemp products across European markets such as the Netherlands, France, Italy, and the United Kingdom.

In addition, Bod revealed that an uptick in prescription volumes of its medicinal cannabis product, MediCabilis, contributed to the sound result.

In addition, the company says that both its cannabis medical division and CBD and Hemp consumer products are generating strong recurring revenue.

Bod further noted that sales growth is expected to continue in the current quarter and foreseeable future. This is backed by the company strategically entering new attractive markets while focusing on growth in Australian and United Kingdom medicinal cannabis sales.

Comments from the CEO

Bod CEO Jo Patterson, hailed the milestone, saying:

The progress achieved over the last quarter is a great result for Bod. The company has considerably broadened its international footprint, with new market entries into the Netherlands, France and Italy, as well as extended its product ranges in the UK. Further, we have increased sales of our medicinal cannabis products in Australia and are now benefitting from this growth.

Demand for our medicinal cannabis, and CBD and hemp products continues to escalate and we expect binding purchase orders to increase during the current period and the remainder of FY2021. Bod has also retained a strong cash balance, which will allow it to progress a number of initiatives including new market entries and product launches. We look forward to updating shareholders on progress over the coming months.

About the Bod share price

The Bod share price has gained 312% over its multi-year low of 12 cents reached in March last year, outperforming the All Ordinaries Index (ASX: XAO) in the same time frame.
Shares in the company hit an all-time high of 74 cents at the start of December.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

white arrow dropping down representing the 10 most shorted shares on the ASX
Share Gainers

Here are the top 10 ASX 200 shares today

It was an absolutely horrid Tuesday for investors.

Read more »

Turning down AGL shares represented by man placing hands up in front of him and frowning
Broker Notes

Brokers say Mesoblast, NAB, and Pilbara Minerals shares are sells

These shares have been hit with sell ratings. But why?

Read more »

Man in mining hat with fists raised and eyes closed looking happy and excited about the Newcrest share price
Share Market News

Why this speculative ASX mining stock could rise 60%+

Let's see why Bell Potter thinks this mining stock could be undervalued by the market.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Broker Notes

Up 57% since April, why this dividend paying ASX All Ords stock is tipped to leap another 25%

A leading broker expects more outperformance from this surging ASX All Ords dividend stock in 2026.

Read more »

A woman gives a side eye look with her lips pursed as though she might be saying ooh at something she's hearing or learning for the first time.
52-Week Lows

Brokers say buy: 3 ASX 200 shares at 52-week lows today

The experts say this is a buying opportunity.

Read more »

Red sell button on an Apple keyboard.
Share Market News

Warning! Analysts name 3 ASX 200 stocks to sell today

After a year of outperformance, analysts tip these three ASX 200 stocks as sells. But why?

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why James Hardie, Meteoric Resources, Pilbara Minerals, and SKS shares are rising today

These shares are avoiding the market selloff on Tuesday. But why?

Read more »

Pieces of paper with percetage rates on them and a question mark.
Share Market News

Buying ASX 200 shares and hoping for interest rate relief? Here's what the RBA minutes reveal

The RBA kept interest rates on hold in November. What can ASX investors expect now?

Read more »